Brian Schimpf

1.2k total citations
18 papers, 967 citations indexed

About

Brian Schimpf is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Brian Schimpf has authored 18 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Neurology. Recurrent topics in Brian Schimpf's work include Heme Oxygenase-1 and Carbon Monoxide (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Brian Schimpf is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Brian Schimpf collaborates with scholars based in United States, United Kingdom and Switzerland. Brian Schimpf's co-authors include Richard A. Zager, D J Gmur, Greg Dietsch, Guy A. Zimmerman, Hai Le Trong, Larry W. Tjoelker, Patrick W. Gray, Stephen M. Prescott, Lawrence S. Cousens and Richard A. Zager and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Brian Schimpf

18 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Schimpf United States 12 370 195 112 97 92 18 967
Zhiming Yang China 18 439 1.2× 144 0.7× 125 1.1× 64 0.7× 29 0.3× 60 972
Yuexin Shan Canada 20 577 1.6× 106 0.5× 288 2.6× 149 1.5× 104 1.1× 31 1.4k
Gavin C. Higgins Australia 21 573 1.5× 156 0.8× 165 1.5× 173 1.8× 154 1.7× 31 1.4k
Hao‐Ai Shui Taiwan 19 561 1.5× 79 0.4× 165 1.5× 58 0.6× 185 2.0× 52 1.1k
Bruns A. Watts United States 22 707 1.9× 113 0.6× 141 1.3× 189 1.9× 266 2.9× 35 1.1k
Ryoji Yamada Japan 16 805 2.2× 102 0.5× 131 1.2× 112 1.2× 38 0.4× 60 1.5k
Liron Walsh United States 14 576 1.6× 245 1.3× 181 1.6× 118 1.2× 269 2.9× 24 1.5k
Usamah S. Kayyali United States 22 606 1.6× 81 0.4× 130 1.2× 219 2.3× 83 0.9× 30 1.2k

Countries citing papers authored by Brian Schimpf

Since Specialization
Citations

This map shows the geographic impact of Brian Schimpf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Schimpf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Schimpf more than expected).

Fields of papers citing papers by Brian Schimpf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Schimpf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Schimpf. The network helps show where Brian Schimpf may publish in the future.

Co-authorship network of co-authors of Brian Schimpf

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Schimpf. A scholar is included among the top collaborators of Brian Schimpf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Schimpf. Brian Schimpf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bauer, Daniel, Lorrene A. Buckley, Heidrun Ellinger‐Ziegelbauer, et al.. (2021). A cross-industry survey on photosafety evaluation of pharmaceuticals after implementation of ICH S10. Regulatory Toxicology and Pharmacology. 125. 105017–105017. 4 indexed citations
2.
Sandall, Sharsti, Marsha L. Mason, Lori Westendorf, et al.. (2019). Abstract 2688: SGN-CD228A: A novel humanized anti-CD228 antibody-drug conjugate for the treatment of solid tumors. Cancer Research. 79(13_Supplement). 2688–2688. 2 indexed citations
3.
Sandall, Sharsti, Marsha L. Mason, Lori Westendorf, et al.. (2019). Abstract 2688: SGN-CD228A: A novel humanized anti-CD228 antibody-drug conjugate for the treatment of solid tumors. 2688–2688. 1 indexed citations
4.
Ryan, Maureen C., Maria Corinna Palanca-Wessels, Brian Schimpf, et al.. (2017). Therapeutic potential of SGN-CD19B, a PBD-based anti-CD19 drug conjugate, for treatment of B-cell malignancies. Blood. 130(18). 2018–2026. 18 indexed citations
5.
Ryan, Maureen C., Brian Schimpf, Martha E. Anderson, et al.. (2015). SGN-CD19B, a Pyrrolobenzodiazepine (PBD)-Based Anti-CD19 Drug Conjugate, Demonstrates Potent Preclinical Activity Against B-Cell Malignancies. Blood. 126(23). 594–594. 4 indexed citations
6.
Zeng, Hongkui, Kyoji Horie, Linda Madisen, et al.. (2008). An Inducible and Reversible Mouse Genetic Rescue System. PLoS Genetics. 4(5). e1000069–e1000069. 64 indexed citations
7.
Zeng, Hongkui, Brian Schimpf, Alex Rohde, et al.. (2007). Thyrotropin-Releasing Hormone Receptor 1-Deficient Mice Display Increased Depression and Anxiety-Like Behavior. Molecular Endocrinology. 21(11). 2795–2804. 59 indexed citations
8.
Zeng, Hongkui, Alexander Gragerov, John G. Hohmann, et al.. (2006). Neuromedin U Receptor 2-Deficient Mice Display Differential Responses in Sensory Perception, Stress, and Feeding. Molecular and Cellular Biology. 26(24). 9352–9363. 58 indexed citations
9.
Jiang, Jimmy J., William Simonson, Jinko Graham, et al.. (1999). Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat.. Diabetes. 48(1). 43–49. 31 indexed citations
10.
Tjoelker, Larry W., Greg Dietsch, Brian Schimpf, et al.. (1995). Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature. 374(6522). 549–553. 445 indexed citations
11.
Zager, Richard A., Mineo Iwata, Kristin M. Burkhart, & Brian Schimpf. (1994). Post-ischemic acute renal failure protects proximal tubules from O2 deprivation injury, possibly by inducing uremia. Kidney International. 45(6). 1760–1768. 73 indexed citations
12.
Hillman, Stanley S. & Brian Schimpf. (1994). Renal Responses to Blood Volume Expansion of Varying Osmotic Concentration in Two Species of Amphibian, Bufo marinus and Rana catesbeiana. Physiological Zoology. 67(4). 995–1005. 5 indexed citations
13.
Zager, Richard A., et al.. (1993). Inorganic iron effects on in vitro hypoxic proximal renal tubular cell injury.. Journal of Clinical Investigation. 91(2). 702–708. 39 indexed citations
14.
Zager, Richard A., Brian Schimpf, D J Gmur, & Thomas J. Burke. (1993). Phospholipase A2 activity can protect renal tubules from oxygen deprivation injury.. Proceedings of the National Academy of Sciences. 90(17). 8297–8301. 36 indexed citations
15.
Zager, Richard A., Brian Schimpf, & D J Gmur. (1993). Physiological pH. Effects on posthypoxic proximal tubular injury.. Circulation Research. 72(4). 837–846. 46 indexed citations
16.
Zager, Richard A., et al.. (1992). Direct amphotericin B-mediated tubular toxicity: Assessments of selected cytoprotective agents. Kidney International. 41(6). 1588–1594. 60 indexed citations
17.
Zager, Richard A., et al.. (1992). Increased proximal tubular cell catalytic iron content. Journal of the American Society of Nephrology. 3(1). 116–118. 6 indexed citations
18.
Zager, Richard A., et al.. (1992). Evidence against increased hydroxyl radical production during oxygen deprivation-reoxygenation proximal tubular injury.. Journal of the American Society of Nephrology. 2(11). 1627–1633. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiming Yang Breakdown of academic impact, for papers by Yuexin Shan Breakdown of academic impact, for papers by Gavin C. Higgins Breakdown of academic impact, for papers by Hao‐Ai Shui Breakdown of academic impact, for papers by Bruns A. Watts Breakdown of academic impact, for papers by Ryoji Yamada Breakdown of academic impact, for papers by Liron Walsh Breakdown of academic impact, for papers by Usamah S. Kayyali
Rankless by CCL
2026